Roman Campbell

Taking a Closer Look At Primoris Services Corp (PRIM) Following Its Recent Trade

Roman Campbell

Primoris Services Corp’s filing revealed that its Director Schauerman John P. acquired Company’s shares for reported $1.06 million on Dec ...

Investing in Vestis Corp (VSTS): What You Must Know

Roman Campbell

Vestis Corp’s recently made public that its Director Goetz William acquired Company’s shares for reported $50082.0 on Dec 08 ’25. ...

MAIA Biotechnology Inc’s latest rating changes from various analysts

Roman Campbell

MAIA Biotechnology Inc’s recent filing unveils that its Director Smith Stan acquired Company’s shares for reported $16441.0 on Dec 05 ...

Recent Insider Activity Suggests Potential Gains for Fox Corporation (FOXA)

Roman Campbell

In a filing, Fox Corporation revealed its Chief Legal and Policy Officer Ciongoli Adam G. unloaded Company’s shares for reported ...

Analyzing SELLAS Life Sciences Group Inc (SLS) After Recent Trading Activity

Roman Campbell

SELLAS Life Sciences Group Inc’s filing revealed that its Director Kalin Katherine Bach acquired Company’s shares for reported $0.1 million ...

Perrigo Company plc [PRGO] Investment Guide: What You Need to Know

Roman Campbell

Perrigo Company plc’s recently made public that its Director Parker Geoffrey M. acquired Company’s shares for reported $0.11 million on ...

The Attractiveness of Investing In UWM Holdings Corporation (UWMC) is Growing

Roman Campbell

UWM Holdings Corporation’s recent filing unveils that its President and CEO Mat Ishbia unloaded Company’s shares for reported $3.43 million ...

Checking in on Kymera Therapeutics Inc (KYMR) after recent insiders movement

Roman Campbell

In a filing, Kymera Therapeutics Inc revealed its Director Booth Bruce unloaded Company’s shares for reported $21.08 million on Dec ...

MACOM Technology Solutions Holdings Inc (MTSI) rating reiterates by TD Cowen

Roman Campbell

MACOM Technology Solutions Holdings Inc’s recently made public that its 10% Owner OCAMPO SUSAN unloaded Company’s shares for reported $23.01 ...

Understanding the Risks of Investing in CRISPR Therapeutics AG (CRSP)

Roman Campbell

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.